Severe Hypertriglyceridemia

Metabolic·MeSH: Hypertriglyceridemia

Prevalence

0.1 / 100K

8 drugs in development·6 companies·11 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
fenofibrate	Amneal Pharmaceuticals, Inc. (AMRX)
vascepa	AMARIN CORP PLCUK (AMRN)

Phase 3(3)

Drug	Company
Pegozafermin	89bio, Inc. (ETNB)
plozasiran	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Plozasiran	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Phase 2(2)

Drug	Company
olezarsen	IONIS PHARMACEUTICALS INC (IONS)
Solbinsiran	ELI LILLY & Co (LLY)

Phase 1(1)

Drug	Company
ARO-APOC3	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

BioSniper tracks 8 drugs in development for Severe Hypertriglyceridemia across 6 companies.

There are 11 clinical trials targeting Severe Hypertriglyceridemia tracked by BioSniper.

The estimated prevalence of Severe Hypertriglyceridemia is approximately 0.1 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.